Cargando…
Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients
Venous thromboembolism (VTE) is common in patients with cancer and is an important contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated only in those cancer patients at highest risk for VTE would be optimal. Risk stratification scores incorporating tumor locat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409200/ https://www.ncbi.nlm.nih.gov/pubmed/32707653 http://dx.doi.org/10.3390/cancers12071958 |